Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 80 entries
View as:

Effectiveness and Safety of the of Guaifenesin, Doxylamine Succinate and Hydrochloride Etafedrine Syrup in Improvement of Symptoms Resulting From Acute Respiratory Infections.

Phase: N/A Priority: Normal
NCT ID: NCT00857987 Org: User:
Start: 04/30/10 End: 12/31/11 Due: 12/31/12

Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot ® (Leuprorelin Acetate - Abbot)

Phase: N/A Priority: Normal
NCT ID: NCT01071005 Org: User:
Start: 08/31/10 End: 01/31/11 Due: 01/31/12

Study To Evaluate The Sensitivity Of The Linda Thermal Device

Phase: N/A Priority: Normal
NCT ID: NCT05009277 Org: User:
Start: 08/30/21 End: 01/30/23 Due: 01/30/24

Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04348409 Org: User:
Start: 05/25/20 End: 12/31/20 Due: 12/31/21

Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT03572647 Org: User:
Start: 11/30/12 End: 05/31/13 Due: 05/31/14

Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT01227915 Org: User:
Start: 02/28/11 End: - Due: -

Sodic Heparin Effectiveness of the Treatment of Burns

Phase: N/A Priority: Normal
NCT ID: NCT00701623 Org: User:
Start: 06/30/08 End: 06/30/08 Due: 06/30/09

Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03252535 Org: User:
Start: 01/15/18 End: 04/30/21 Due: 04/30/22

Effectiveness of Glucosamine + Chondroitin in Osteoarthrosis

Phase: N/A Priority: Normal
NCT ID: NCT00860873 Org: User:
Start: 10/31/09 End: 11/30/10 Due: 11/30/11

Efficacy and Safety of Sodium Heparin

Phase: N/A Priority: Normal
NCT ID: NCT00894985 Org: User:
Start: 06/30/09 End: 12/31/11 Due: 12/31/12

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration

Phase: N/A Priority: Normal
NCT ID: NCT01692171 Org: User:
Start: 02/28/13 End: 10/31/13 Due: 10/31/14

Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk.

Phase: N/A Priority: Normal
NCT ID: NCT01666249 Org: User:
Start: 04/30/14 End: 12/31/20 Due: 12/31/21

Pharmacodynamics Aspects Of Porcine Heparin Sodium, Produced by Eurofarma, Compared Heparin Sodium, Produced by APP Pharmaceuticasls, in Patients With Chronic Renal Failure

Phase: N/A Priority: Normal
NCT ID: NCT01034488 Org: User:
Start: 08/31/10 End: 02/29/12 Due: 02/28/13

Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04348474 Org: User:
Start: 04/20/20 End: 07/31/23 Due: 07/31/24

Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.

Phase: N/A Priority: Normal
NCT ID: NCT01228630 Org: User:
Start: 08/31/11 End: 05/31/12 Due: 05/31/13

PK and PD Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01664195 Org: User:
Start: 02/28/13 End: 10/31/13 Due: 10/31/14

Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04435314 Org: User:
Start: 06/30/20 End: 08/31/20 Due: 08/31/21

Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®.

Phase: N/A Priority: Normal
NCT ID: NCT01480778 Org: User:
Start: 07/31/14 End: 06/30/15 Due: 06/30/16

Efficacy and Safety of a New Botulinum Toxin Type A for Treatment of Facial Expression Lines

Phase: N/A Priority: Normal
NCT ID: NCT01180348 Org: User:
Start: 08/31/11 End: 09/30/12 Due: 09/30/13

Safety of UFRJvac, Trivalent COVID-19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT06303635 Org: User:
Start: 06/24/24 End: 11/25/25 Due: 11/25/26

Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02728115 Org: User:
Start: 10/16/17 End: 12/31/23 Due: 12/31/24

Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin

Phase: N/A Priority: Normal
NCT ID: NCT01119534 Org: User:
Start: 05/31/11 End: 12/31/11 Due: 12/31/12

Efficacy and Comparative of the Association Beclomethasone Clotrimzaol + Gentamicin in Patients With Acne Contaminated

Phase: N/A Priority: Normal
NCT ID: NCT01244256 Org: User:
Start: 04/30/07 End: 09/30/07 Due: 09/30/08

Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.

Phase: N/A Priority: Normal
NCT ID: NCT01549301 Org: User:
Start: 08/31/12 End: 09/30/13 Due: 09/30/14

Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00715975 Org: User:
Start: 07/31/08 End: 08/31/10 Due: 08/31/11